Evan Cheng
Co-founder & CEO @ Mysten Labs
Burlingame, United States
Evan Cheng is a seed investor at Mysten Labs in Burlingame focused on Software and Artificial Intelligence. Evan Cheng Co-founder & CEO at Mysten Labs. He attended Syracuse University.
- Total investments:
- 27
- Last investment:
- Lead investor:
- 4%
Last updated:
For AI agents: llms.txt
Industries Evan Cheng invests in
Stages Evan Cheng invests in
Countries Evan Cheng invests in
Round sizes
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Round size
- Seed
- $120k–$5.8M
- Pre-Seed
- $150k–$10M
- Series A
- $3M–$18M
Investment Focus
Industry
- Software 9 (33%)
- Artificial Intelligence 6 (22%)
- Biotechnology 5 (19%)
- Enterprise Software 5 (19%)
- Security 4 (15%)
Stage
- Seed 16 (59%)
- Pre-Seed 4 (15%)
- Series A 3 (11%)
- Funding Round 2 (7%)
- Venture - Series Unknown 1 (4%)
Country
- United States 21 (78%)
- United Kingdom 2 (7%)
- Australia 1 (4%)
- Switzerland 1 (4%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Kite AI
|
Kite AI is a purpose-built, EVM-compatible L1 designed to power the AI economy. | $18M / Series A / Sep 02, 2025 | |
Kontigo
|
We help underbanked gig workers in Latam build credit and access group financing where small groups of family or friends lend and save money together. Users can validate their income from multiple sources such as gig apps, catalog sales, and open finance (Uber, Rappi, Didi, Indriver, Avon, and all major banks). After verifying the income wedirectly offer them group savings and group loans, without leaving WhatsApp, their primary messaging app. | $20M / Seed / Sep 01, 2025 | |
Jarsy
|
Jarsy Inc offers a platform for global investment opportunities using stablecoins. | $5M / Pre-Seed / Jun 26, 2025 | |
PIN AI
|
PIN AI democratizes personal on-device intelligence for everyone; transform your digital footprints into your Personal Executive Assistant. | $10M / Pre-Seed / Sep 09, 2024 | |
Verida
|
Verida is a decentralized data platform that empowers users to take control of their personal data and digital identities. The company provides a secure wallet and network infrastructure to enable users to manage their crypto assets, verifiable credentials, and encrypted personal data. Verida merged with Kwaai in 2025. | $5M / Seed / Jun 21, 2024 | |
Anapaya
|
The SCION Internet architecture developed at ETH Zurich is a disruptive technology that provides secure inter-domain routing, QoS, DDoS defense mechanisms, resilient public-key infrastructures, and an unprecedented level of availability. We leverage the SCION architecture to offer next-generation Internet services and address the flaws andlimitations of today’s Internet. | $1.9M / Venture - Series Unknown / Oct 25, 2023 | |
PARSIQ
|
PARSIQ is a blockchain monitoring and event tracking platform. It offers tools for analyzing, detecting, and preventing cryptocurrency fraud. PARSIQ is a brand new tool for Bitcoin, Ethereum, and other Blockchain transaction tracking. The platform provides a transparent way of obtaining an analytical view of the transaction history of differentblockchains. It also provides real-time monitoring of accounts, transactions, and related blockchain state. PARSIQ supports both B2B and B2C business models, offering services to enterprises and private users. | $3M / Series A / Jun 15, 2021 | |
|
Verida
|
Verida is a decentralized data platform that empowers users to take control of their personal data and digital identities. The company provides a secure wallet and network infrastructure to enable users to manage their crypto assets, verifiable credentials, and encrypted personal data. Verida merged with Kwaai in 2025. | $3M / Seed / Jun 15, 2021 | |
Kernal Biologics
|
Kernal creates mRNA therapies to cure diseases like COVID and cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. Kernal won three awards from Amgen and NASA. With roots at MIT, Harvard and Big Pharma, the team previously built a successful Biotech company and has deep expertise in mRNA space. | Seed / Oct 25, 2020 | |
SiPhox Health
|
SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA. | $5.8M / Seed / Oct 24, 2020 | |
| See all 27 investments → | |||
Co-Investors
About Mysten Labs
Mysten Labs develops tools that make web3 secure, reliable, and ready for mass adoption.
Mysten Labs Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Anthony Palma
Head of Gaming Partnerships
|
|||
|
Evan Cheng
Co-founder & CEO
|
|||
George Danezis
Co-founder & Chief Scientist
|
|||
Tom Harbert
Production Engineer
|
|||
Adeniyi Abiodun
Co-founder & CPO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Evan Cheng invest in?
Evan Cheng invests primarily in Software, Artificial Intelligence and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 27 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Evan Cheng's check size?
Evan Cheng typically joins rounds of $120k–$5.8M at Seed, $150k–$10M at Pre-Seed and $3M–$18M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Evan Cheng participates in.
How do I contact Evan Cheng?
Public channels for Evan Cheng include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Evan Cheng last invest?
The most recent investment recorded for Evan Cheng closed in Sep 2025. Shizune tracks 27 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
